1-7 of 7
Thomas J. Sayers
Close
Sort by
Journal Articles

Differential effects of donor T-cell cytokines on outcome with continuous bortezomib administration after allogeneic bone marrow transplantation

Kai Sun, Minghui Li, Thomas J. Sayers, Lisbeth A. Welniak, William J. Murphy
Journal: Blood
Blood (2008) 112 (4): 1522–1529.
https://doi.org/10.1182/blood-2008-03-143461
Published: 2008
Journal Articles

Dissociating GVT from GVHD in Murine BMT Models through TNFα Dependent CD4+ T Cell Mediated GVHD and IFNγ Dependent CD8+ T Cell Mediated Anti-Tumor Effects.

William J. Murphy, PhD, Minghui Li, Angela Panoskaltsis-Mortari, PhD, Bruce R. Blazar, MD, Thomas J. Sayers, PhD, Sergei Nedospasov, PhD, Dennis D. Taub, PhD, Lisbeth A. Welniak, PhD, Kai Sun, PhD
Journal: Blood
Blood (2007) 110 (11): 69.
https://doi.org/10.1182/blood.V110.11.69.69
Published: 2007
Journal Articles

Removal of Donor CD4+ T Cells Markedly Promotes Graft-Versus-Tumor (GVT) Effects and Inhibits GVHD-Dependent Toxicity Associated with Prolonged Bortezomib Administration after Allogeneic BMT.

William J. Murphy, PhD, Lisbeth A. Welniak, PhD, Minghui Li, Thomas J. Sayers, PhD, Angela Panoskaltsis-Mortari, PhD, Bruce R. Blazar, MD, Kai Sun, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 3160.
https://doi.org/10.1182/blood.V108.11.3160.3160
Published: 2006
Journal Articles

Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity

Kai Sun, Danice E. C. Wilkins, Miriam R. Anver, Thomas J. Sayers, Angela Panoskaltsis-Mortari, Bruce R. Blazar, Lisbeth A. Welniak, William J. Murphy
Journal: Blood
Blood (2005) 106 (9): 3293–3299.
https://doi.org/10.1182/blood-2004-11-4526
Published: 2005
Journal Articles

Mcl-1 reduction: releasing a death brake?

Thomas J. Sayers
Journal: Blood
Blood (2005) 105 (8): 3005.
https://doi.org/10.1182/blood-2005-01-0290
Published: 2005
Journal Articles

The proteasome inhibitor PS-341 sensitizes neoplastic cells to TRAIL-mediated apoptosis by reducing levels of c-FLIP

Thomas J. Sayers, Alan D. Brooks, Crystal Y. Koh, Weihong Ma, Naoko Seki, Arati Raziuddin, Bruce R. Blazar, Xia Zhang, Peter J. Elliott, William J. Murphy
Journal: Blood
Blood (2003) 102 (1): 303–310.
https://doi.org/10.1182/blood-2002-09-2975
Published: 2003
Journal Articles

Antigen-primed CD8 + T cells can mediate resistance, preventing allogeneic marrow engraftment in the simultaneous absence of perforin-, CD95L-, TNFR1-, and TRAIL-dependent killing

Masanobu Komatsu, Michele Mammolenti, Monica Jones, Roland Jurecic, Thomas J. Sayers, Robert B. Levy
Journal: Blood
Blood (2003) 101 (10): 3991–3999.
https://doi.org/10.1182/blood-2002-09-2859
Published: 2003